The first endovascular neural interface, the Stentrode™ is a minimally invasive implantable brain device that can interpret signals from the brain for patients with paralysis. Implanted via the jugular vein, the Stentrode is placed inside the brain in the command-control centre, known as the motor cortex, but without the need for open brain surgery. The signals are captured and sent to a wireless antenna unit implanted in the chest, which sends them to an external receiver. We are building a software suite that enables the patient to learn how to control a computer operating system and set of applications that interact with assistive technologies. This technology has the potential to enable patients with paralysis to take back digital control of their world, without having to move a muscle.
Synchron is currently preparing for pilot clinical trials of the Stentrode™ to evaluate the safety and efficacy of this breakthrough technology.